Learn more about the benefits of registering on the new BJS website

Management of intrahepatic recurrence after curative treatment of colorectal liver metastases. BJS 2006; 93: 854-859.

Published: 16th May 2006

Authors: T. D. Yan, K. Q. Lian, D. Chang, D. L. Morris


Management of intrahepatic recurrence after complete surgical treatment for colorectal liver metastases is not well defined. The aim of this study was to analyse the survival results of patients who had repeat liver resection for intrahepatic recurrence and to evaluate prognostic indicators for survival.


Between 1991 and 2005, 55 patients had repeat liver resection for isolated intrahepatic recurrence. The long‐term survival results were assessed. Univariable and multivariable analyses were used to identify prognostic indicators for survival after repeat hepatectomy.


The median survival was 53 (range 2–97) months and the 5‐year survival rate was 49 per cent. In univariable analysis, size of largest initial liver metastasis, margin of initial liver surgery, carcinoembryonic antigen (CEA) level before and after initial liver surgery, liver disease‐free survival, margin of repeat liver surgery, operation type of repeat surgery and CEA level before and after repeat surgery were significant prognostic factors. In multivariable analysis, largest initial liver metastasis 4 cm or less and CEA level 5 ng/ml or less after repeat liver surgery were independently associated with improved survival.


Repeat hepatectomy can achieve an acceptable survival in selected patients with isolated intrahepatic recurrence. Copyright © 2006 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Full text

Your comments